Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
5,000
NCT05715853
Prospective Assessment of Rejection in Kidney Transplant (PARK)
Phase: N/A
Role: Lead Sponsor
Start: Dec 20, 2022
Completion: Sep 30, 2023
NCT05282966
Assessment of QSant™ for Underlying Allograft Rejection
Start: Mar 31, 2023
Completion: Oct 31, 2026